Tanke Biosciences Financials
| TNBI Stock | USD 0.01 0.00 0.00% |
Tanke |
Understanding current and past Tanke Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Tanke Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Tanke Biosciences' assets may result in an increase in income on the income statement.
Tanke Biosciences Stock Summary
Tanke Biosciences competes with Embrace Change. Tanke Biosciences Corporation, through its subsidiaries, develops, produces, markets, and sells animal nutrition and feed additive products. Tanke Biosciences Corporation was founded in 1989 and is headquartered in Guangzhou, the Peoples Republic of China. TANKE BIOSCIENCES operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 130 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | East Tower of |
| Sector | Financial Services |
| Industry | Shell Companies |
| Benchmark | Dow Jones Industrial |
| Website | www.tanke-bio.com |
| Phone | 86 20 3885 9025 |
| Currency | USD - US Dollar |
Tanke Biosciences Key Financial Ratios
Tanke Biosciences' financial ratios allow both analysts and investors to convert raw data from Tanke Biosciences' financial statements into concise, actionable information that can be used to evaluate the performance of Tanke Biosciences over time and compare it to other companies across industries.| Return On Equity | -0.1 | |||
| Return On Asset | -0.0012 | |||
| Number Of Employees | 130 | |||
| Beta | 0.96 |
Tanke Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tanke Biosciences's current stock value. Our valuation model uses many indicators to compare Tanke Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tanke Biosciences competition to find correlations between indicators driving Tanke Biosciences's intrinsic value. More Info.Tanke Biosciences is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Tanke Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tanke Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Tanke Biosciences Systematic Risk
Tanke Biosciences' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tanke Biosciences volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Tanke Biosciences correlated with the market. If Beta is less than 0 Tanke Biosciences generally moves in the opposite direction as compared to the market. If Tanke Biosciences Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tanke Biosciences is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tanke Biosciences is generally in the same direction as the market. If Beta > 1 Tanke Biosciences moves generally in the same direction as, but more than the movement of the benchmark.
Tanke Biosciences November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tanke Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tanke Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tanke Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Tanke Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tanke Biosciences's daily price indicators and compare them against related drivers.
| Downside Deviation | 43.47 | |||
| Information Ratio | 0.0984 | |||
| Maximum Drawdown | 450.0 | |||
| Value At Risk | (33.33) | |||
| Potential Upside | 33.33 |
Complementary Tools for Tanke Pink Sheet analysis
When running Tanke Biosciences' price analysis, check to measure Tanke Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanke Biosciences is operating at the current time. Most of Tanke Biosciences' value examination focuses on studying past and present price action to predict the probability of Tanke Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanke Biosciences' price. Additionally, you may evaluate how the addition of Tanke Biosciences to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |